News and Announcements
Phylogica Ltd – European Patent Granted Covering Phylomer Peptides For Ischemia
- Published April 24, 2013 2:29PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
PERTH, AUSTRALIA: April 24, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, has been granted a new European patent (no. 1793841) entitled: ‘Peptide inhibitors of c-‐Jun dimerization and uses thereof’. This international patent (PCT/AU2005/001255) covers the Company’s lead Phylomer peptides targeting the AP-‐1 pathway, which is a crucial mediator of inflammation and cell death in multiple diseases.
The AP-‐1 pathway plays a critical role in neuronal cell death caused by stroke and traumatic brain injury, and lung inflammation resulting from acute respiratory distress syndrome (ARDS) and septic shock. The family of Phylomer peptides has demonstrated efficacy in multiple preclinical models for stroke, traumatic brain injury and ARDS. The granted claims of the patent cover any use of these Phylomers in the treatment of ischemic disease, including important clinical settings such as stroke, traumatic brain injury and reperfusion injury of liver, heart and blood vessels following transplantation. Ischemia, or insufficient blood supply is a critical cause of inflammation and cell death. Often this damage is exacerbated when blood supply returns to the vessel or organ. The peptides covered by this patent are active in this pathway and help to reduce the collateral damage to tissue.
To read the full ASX announcement please download the document below.
Company Updates
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
Backed By Leading Investment Groups and Family Offices
